Drug: Zepatier (elbasvir/grazoprevir)

Manufacturer: Merck

Route of Administration: Oral

Site of Care: Outpatient

Approved Indication: treatment of adults with chronic HCV genotype 1 or 4 infection without cirrhosis or with compensated cirrhosis in combination with ribavirin for certain patient populations

Disease: chronic viral hepatitis C

Therapeutic Area: Infectious disease, Gastroenterology, Hepatology

Enrollment Form Link: N/A

Phone Number: N/A

Fax Number: N/A

Product Website: N/A